Yangbo Feng

Also affiliated with Sylvester Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyChemistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Targeted Therapy Development in Acute Myeloid Leukemia”.

Targeted Therapy Development in Acute Myeloid Leukemia

Biomedicines(2023)10.3390/biomedicines11020641

N/A

0DataRank · unranked

52 citations

Anirban Ghoshal, Jenna Zabroski, Anya K. Sondhi, Saanvi Bucha, Jacob Jahn +3 more

Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents

British Journal of Cancer(2024)10.1038/s41416-024-02760-1

N/A

0DataRank · unranked

13 citations

Valentina Foglizzo, Guilherme Harada, Matteo Repetto, Amanda Kulick, Elisa de Stanchina +17 more

Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.4c00125

N/A

0DataRank · unranked

3 citations

Jesus R. Castro, Tulasigeri M. Totiger, Jumana Afaghani, Rabia Khurshid, M. Gary Nicholls +6 more

Structural Study of Selectivity Mechanisms for JNK3 and p38α with Indazole Scaffold Probing Compounds

Research Square(2024)10.21203/rs.3.rs-4730282/v1

N/A

0DataRank · unranked

0 citations

Yangbo Feng, HaJeung Park

Structural study of selectivity mechanisms for JNK3 and p38α with indazole scaffold probing compounds

Journal of Molecular Structure(2025)10.1016/j.molstruc.2025.142179

N/A

0DataRank · unranked

1 citations

Yangbo Feng, HaJeung Park